Revolution Medicines Director Files Form 144 to Sell $2.91M via Option Exercise
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Proposed sale of 15,080 common shares (~$2.91M) by Director Elizabeth Anderson at an estimated price of ~$192.76 per share. The shares originate from option exercises under a Rule 10b5-1 plan adopted June 23, 2026.
Comprehensive Analysis
Overview
On September 22, 2026, Elizabeth Anderson, a Director of Revolution Medicines, Inc. (NASDAQ: RVMD), filed a Form 144 disclosing a proposed sale of 15,080 shares of common stock with an aggregate market value of approximately $2,906,820.80.
Transaction Details
- Security: Common Stock
- Number of Shares: 15,080
- Estimated Aggregate Market Value: $2,906,820.80 (~$192.76 per share)
- Acquisition Nature: Exercise of Stock Options
- Broker: Morgan Stanley Smith Barney LLC
- Trading Plan: Pre-arranged Rule 10b5-1 plan adopted on June 23, 2026
- Shares Outstanding: 214,336,418 shares
Market & Governance Impact
- Dilution / Float Impact: The proposed sale represents approximately 0.007% of Revolution Medicines' 214.3M shares outstanding, indicating negligible supply pressure on the market.
- Pre-Scheduled Nature: The transaction is conducted pursuant to a Rule 10b5-1 trading plan established three months prior, reflecting routine portfolio management via option exercise rather than discretionary sentiment-driven selling.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.